Key player · Company profile
Johnson & Johnson
Named as a key player in 891 of our reports, across 33 regions and countries.
Named as a key player in 891 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
Australia 27
Brazil 27
Canada 27
China 27
Ecuador 27
Egypt 27
France 27
Germany 27
Hong Kong 27
India 27
Italy 27
Japan 27
Kenya 27
Malaysia 27
Mexico 27
New Zealand 27
Philippines 27
Russia 27
Saudi Arabia 27
Singapore 27
South Africa 27
Spain 27
Thailand 27
UAE 27
UK 27
US 27| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Over The Counter (OTC) Drugs | OTC & Nutraceuticals | $178 Bn | 4.7% |
| Over The Counter (OTC) Pharmaceuticals | OTC & Nutraceuticals | $178 Bn | 4.7% |
| Oncology/Cancer Drugs | Pharmaceuticals | $177 Bn | 8.4% |
| Over The Counter (OTC) Consumer | OTC & Nutraceuticals | $151 Bn | 5.2% |
| Over The Counter (OTC) Vitamins and Minerals | OTC & Nutraceuticals | $32 Bn | 5.5% |
| HIV Drugs | Pharmaceuticals | $30 Bn | 5.8% |
| Contraceptives Drugs | Pharmaceuticals | $25.2 Bn | 6.8% |
| Over The Counter (OTC) Analgesics | OTC & Nutraceuticals | $22 Bn | 3.4% |
| Anti-Depressants Drugs | Pharmaceuticals | $18 Bn | 2.7% |
| Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs | OTC & Nutraceuticals | $14.5 Bn | 4.1% |
| Over The Counter (OTC) Gastrointestinal Drugs | OTC & Nutraceuticals | $5.6 Bn | 3.9% |
| 3D Printed Implants | Digital Health | $3.6 Bn | 13.5% |
| Anastomosis Devices | Medical Devices | $3.2 Bn | 6.8% |
| Advanced Bipolar Direct Energy Devices | Medical Devices | $3.1 Bn | 8.7% |
| Artificial Skin | Pharmaceuticals | $2.5 Bn | 5.8% |
| Alzheimers Dignostic | Healthcare Services | $2.1 Bn | 6.9% |
| Remote Patient Monitoring | Digital Health | $1.6 Bn | 17.8% |
| Bone Cancer Diagnostic | Healthcare Services | $1.1 Bn | 7.4% |
| Brain Imaging, Biomarkers and NeuroInformatics | Digital Health | $680 Mn | 4.7% |
| Alopecia areata | Healthcare Services | – | – |
| Alopecia Drugs (Hair Loss) | Pharmaceuticals | – | – |
| Anticoagulants | Pharmaceuticals | – | – |
| Antipyretics OTC | OTC & Nutraceuticals | – | – |
| Antithrombotic Drugs | Pharmaceuticals | – | – |
| Axial Spondyloarthritis (axSpA) | Pharmaceuticals | – | – |
| Burn Care | Pharmaceuticals | – | – |
| Burn Ointment | Pharmaceuticals | – | – |
Named as key players in the same markets as Johnson & Johnson (number of shared markets).
Merck & Co., Inc.9 shared markets
AstraZeneca8 shared markets
Pfizer Inc.8 shared markets
AbbVie Inc.7 shared markets
Novartis AG7 shared markets
Sanofi7 shared markets
Abbott Laboratories6 shared markets
Bayer AG6 shared markets